Status:
COMPLETED
Complementary Intervention for COVID-19
Lead Sponsor:
Egyptian Biomedical Research Network
Conditions:
COVID-19
Eligibility:
All Genders
12-65 years
Phase:
NA
Brief Summary
Boswellia Serrata gum and Licorice extract are two nutritional agents that have pharmacological actions that could support the medical intervention for COVID-19. They have broad antiviral activity, an...
Detailed Description
Since last December 2019, a syndrome of severe pneumonia associated with the coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province, China. It is highly contagious and rapidly spread to ...
Eligibility Criteria
Inclusion
- Symptomatic and laboratory-confirmed diagnosis of COVID-19.
- RT-PCR indicates positive for novel coronavirus RNA
- Viral specific IgM and IgG are detectable in serum
- Viral specific IgG is detectable from negative to positive, OR
- Viral specific IgG antibody reaches a titration of at least 4-fold higher in the recovery stage than in the acute stage
Exclusion
- Patients who are not fulfilling the diagnostic criteria for COVOID-19.
- Pregnant women.
- Critically ill patients who are mechanically ventilated since admission.
- Hypertensive patients.
- Congestive heart failure patients
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04487964
Start Date
January 1 2020
End Date
December 1 2021
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Assiut University
Asyut, Egypt